김용준 (경희대학교 의과대학)님 | 한빛사연구자 > 한빛사

경희대학교 의과대학

최종업데이트 2024.05.16.

SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model
- Cell Rep. Med., May 10 2024, S2666-3791(24)00262-3 | https://doi.org/10.1016/j.xcrm.2024.101570
- 2024-05
- 의약학
- 한빛사논문
Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients
- Emerg. Microbes Infect., Dec 2022, 11 (1) | https://doi.org/10.1080/22221751.2021.2024095
- 2022-12
- 의약학
- 한빛사논문
New insights into the epitranscriptomic control of pluripotent stem cell fate
- Exp. Mol. Med., 2022 Oct;54(10):1643-1651 | doi: 10.1038/s12276-022-00824-x
- 2022-10
- 의약학
- 한빛사논문
Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder
- Nat. Biomed. Eng., July 2019, 3, pages 571-582 | DOI https://doi.org/10.1038/s41551-019-0381-8
- 2019-07
- 의약학
- 한빛사논문
Generation of Multipotent Induced Neural Crest by Direct Reprogramming of Human Postnatal Fibroblasts with a Single Transcription Factor
- Cell Stem Cell, Available online 21 August 2014, DOI: http://dx.doi.org/10.1016/j.stem.2014.07.013
- 2014-08
- 의약학
- 한빛사논문
[Preview]Candidate ALS Therapeutics Motor toward “In Vitro Clinical Trials”
- Cell Stem Cell, Volume 12, Issue 6, 6 June 2013, Pages 633–634 | http://dx.doi.org/10.1016/j.stem.2013.05.009
- 2013-06
- 의약학
- 한빛사논문

연구자 ID

저자논문